Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 35 (RPL34P35)

Target
RPL34P35
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L34 pseudogene 35 (RPL34P35) is a pseudogene in humans, related by sequence similarity to the functional ribosomal protein L34 gene (RPL34), which encodes a structural constituent of the large (60S) ribosomal subunit involved in protein synthesis. Pseudogenes like RPL34P35 are typically non-functional, meaning they do not encode functional proteins; instead, they are genomic DNA sequences similar to functional genes but are generally considered transcriptionally inactive, lacking an active biological role. RPL34P35, along with many other processed ribosomal protein pseudogenes, is dispersed across the human genome and primarily serves as a genomic landmark of evolutionary history rather than as an active molecular target[1][7][5][4]. Context & Interpretation: - RPL34P35 is specifically identified as a pseudogene, not as a protein-coding gene or an active receptor, enzyme, transporter, or other therapeutic drug target[1][7]. - No evidence indicates a direct role in disease, active biological function, clinical biomarker utility, drug interaction, or mechanism of action. All such roles pertain to its functional counterpart, ribosomal protein L34 (RPL34)[5][4]. - Its naming conventions and aliases follow typical numbering in the processed ribosomal pseudogene family[7]. - No functional, pharmacological, or clinical data are available for this entity, because this is common for ribosomal protein pseudogenes, which do not encode functional proteins in the human genome[1][5][4]. If you need information about the functional ribosomal protein L34 (RPL34), let me know for details on its molecular classifications, roles in ribosome structure/function, and disease associations.

Other names
RPL34_16_1738RPL34P35
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 35 (RPL34P35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 35 (RPL34P35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call